This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively | MicrobiomeTrials
← Back to trials NCT07424404
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-04-07Est. Completion: 2030-03-08
Enrollment target: 400 participantsLocations Local Institution - 0054, Dothan, Alabama, United States Local Institution - 0163, Phoenix, Arizona, United States Advanced Research Center Inc., Anaheim, California, United States Local Institution - 0159, Anaheim, California, United States Inland Psychiatric Medical Group., Chino, California, United States Proscience Research Group, Culver City, California, United States Local Institution - 0162, Glendale, California, United States Local Institution - 0153, Los Angeles, California, United States Local Institution - 0158, Orange, California, United States Local Institution - 0174, San Diego, California, United States Local Institution - 0089, San Francisco, California, United States Local Institution - 0157, San Rafael, California, United States Local Institution - 0161, Colorado Springs, Colorado, United States Local Institution - 0154, New Haven, Connecticut, United States Local Institution - 0145, Boca Raton, Florida, United States Local Institution - 0160, Gainesville, Florida, United States Other microbiome trials you might be interested in SCHIZOPHRENIA 1 (Disorder)
This randomized controlled trial (RCT) is the first to evaluate the efficacy and safety of a multi-target TMS protocol t…
Shanghai, China Est. completion Dec 30, 2027
Schizoaffective Disorder
Schizoaffective disorder (SAD) is a chronic psychiatric condition characterized by psychotic and mood symptoms. Emerging…
Elâzığ, Turkey (Türkiye) Completed Jun 2, 2026
Local Institution - 0164, Gainesville, Florida, United States
Local Institution - 0168, Hollywood, Florida, United States
Apg Research, Llc, Orlando, Florida, United States
Atlanta Center for Medical Research, Atlanta, Georgia, United States
Salveo Integrative Health - Lawrenceville, Lawrenceville, Georgia, United States
Denali Health Atlanta, LLC, Stone Mountain, Georgia, United States
Local Institution - 0175, Chicago, Illinois, United States
EmVenio Research Center - Prime Healthcare, Chicago, Illinois, United States
Boston Children's Hospital, Boston, Massachusetts, United States
Local Institution - 0132, Lexington, Massachusetts, United States
Local Institution - 0059, Worcester, Massachusetts, United States
Local Institution - 0152, Bloomfield Hills, Michigan, United States
Local Institution - 0142, Columbia, Missouri, United States
Local Institution - 0147, Lincoln, Nebraska, United States
Local Institution - 0144, Las Vegas, Nevada, United States
Local Institution - 0146, Neptune City, New Jersey, United States
Local Institution - 0061, Great Neck, New York, United States
Local Institution - 0156, Staten Island, New York, United States
Local Institution - 0151, The Bronx, New York, United States
University of Cincinnati Cancer Institute, Cincinnati, Ohio, United States
Local Institution - 0148, Cincinnati, Ohio, United States
Local Institution - 0139, West Chester, Ohio, United States
Local Institution - 0143, Danville, Pennsylvania, United States
Local Institution - 0150, Pittsburgh, Pennsylvania, United States
Local Institution - 0137, Nashville, Tennessee, United States
Local Institution - 0149, Dallas, Texas, United States
VAST Clinical Research, Garland, Texas, United States
Local Institution - 0169, Houston, Texas, United States
Local Institution - 0165, Plano, Texas, United States
Local Institution - 0176, Plano, Texas, United States
Local Institution - 0066, Spring, Texas, United States
Local Institution - 0141, Orem, Utah, United States
Local Institution - 0167, West Point, Utah, United States
Local Institution - 0050, Richmond, Virginia, United States
Local Institution - 0155, Everett, Washington, United States
Local Institution - 0107, Westmead, New South Wales, Australia
Local Institution - 0106, Brisbane, Queensland, Australia
Local Institution - 0108, Melbourne, Victoria, Australia
Local Institution - 0109, Melbourne, Victoria, Australia
Local Institution - 0138, Calgary, Alberta, Canada
Local Institution - 0111, Edmonton, Alberta, Canada
Local Institution - 0110, Kingston, Ontario, Canada
Local Institution - 0113, Toronto, Ontario, Canada
Local Institution - 0112, Montreal, Quebec, Canada
Local Institution - 0118, Bordeaux, France
Local Institution - 0120, Bron, France
Local Institution - 0119, Paris, France
Local Institution - 0129, Budapest, Hungary
Local Institution - 0130, Gyula, Hungary
Local Institution - 0131, Szeged, Hungary
Local Institution - 0075, Chikugo, Fukuoka, Japan
Goryokai Medical Corporation - Goryokai Hospital, Sapporo, Hokkaido, Japan
Local Institution - 0025, Zentsujichó, Kagawa-ken, Japan
Local Institution - 0062, Miyakonojō, Miyazaki, Japan
Local Institution - 0086, Bunkyo-ku, Tokyo, Japan
Local Institution - 0056, Ōta-ku, Tokyo, Japan
Local Institution - 0063, Yokohama, Kanagawa, Japan
Local Institution - 0128, Poznan, Greater Poland Voivodeship, Poland
Local Institution - 0125, Wroclaw, Lower Silesian Voivodeship, Poland
Local Institution - 0127, Warsaw, Masovian Voivodeship, Poland
Local Institution - 0126, Gdansk, Pomeranian Voivodeship, Poland
Local Institution - 0123, Szczecin, West Pomeranian Voivodeship, Poland
Local Institution - 0121, Gdansk, Poland
Local Institution - 0124, Katowice, Poland
Local Institution - 0122, Lublin, Poland
Local Institution - 0029, Bucharest, Bucharest, Romania
Local Institution - 0040, Bucharest, Romania
Cabinet Medical Individual Dr Gheorghita Karina Lidia, Bucharest, Romania
Cluj Napoca Emergency Hospital for Children, Department of Pediatric Psychiatry, Cluj-Napoca, Romania
Local Institution - 0008, Iași, Romania
Emergency Clinical Hospital For Children Louis Turcanu Timis, Timișoara, Romania
Local Institution - 0101, Barcelona, Spain
Local Institution - 0099, Barcelona, Spain
Local Institution - 0098, Madrid, Spain
Local Institution - 0100, Madrid, Spain Treatment-resistant Schizophrenia
This is a prospective, 12-week, randomized, double-blind, placebo-controlled study, designed to evaluate the efficacy, s…
Los Angeles, United States Est. completion Mar 31, 2027